Please provide your email address to receive an email when new articles are posted on . Findings from a meta-regression analysis indicated that the beneficial effects of SGLT2 inhibition on CV death ...
When canagliflozin (Invokana) was approved in 2013, the SGLT2 inhibitor was touted as a first in a new medication class that was, at the time, the only oral, once-daily medication to reduce blood ...
SGLT2 inhibitors combat inflammation and slow kidney disease by elevating S-adenosylmethionine (SAM) levels, which suppress inflammatory gene activity through epigenetic modification. The benefits of ...
STOCKHOLM — In the treatment of type 2 diabetes, sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) show independent benefits that complement ...
Dr. Butler answers the question: 'Side Effects Of ACE Inhibitors?' — -- Question: What are the benefits and side effects of ACE Inhibitors? Answer: There are a lot of benefits to ACE inhibitor ...
A new meta-analysis of more than a dozen clinical trials confirms the clinical benefit of sodium glucose cotransporter 2 (SGLT2) inhibitors for patients with heart failure (HF). The pooled data from ...
Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors had a lower risk for rheumatic disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results